Oral nifedipine versus intravenous labetalol for severe hypertension during pregnancy: A systematic review and meta-analysis

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 123, Issue 1, 2016, Pages 40-47

  Shekhar, S ^a   Gupta, N ^a   Kirubakaran, R ^b   Pareek, P ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b CHRISTIAN MEDICAL COLLEGE   (India)

Author keywords

Labetalol; meta analysis nifedipine; severe hypertension during pregnancy; severe pre eclampsia

Indexed keywords

LABETALOL; NIFEDIPINE; ANTIHYPERTENSIVE AGENT;

BLOOD PRESSURE REGULATION; CESAREAN SECTION; DEVELOPING COUNTRY; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; EVIDENCE BASED MEDICINE; FETUS DEATH; FETUS HEART RATE; FETUS OUTCOME; HUMAN; MATERNAL HYPERTENSION; MATERNAL MORBIDITY; MATERNAL MORTALITY; META ANALYSIS; NEWBORN DEATH; NEWBORN INTENSIVE CARE; OUTCOME ASSESSMENT; PREGNANCY OUTCOME; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK REDUCTION; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; UNSPECIFIED SIDE EFFECT; ADULT; CLINICAL PRACTICE; COMPARATIVE STUDY; COST BENEFIT ANALYSIS; ECONOMICS; FEMALE; HYPERTENSION, PREGNANCY-INDUCED; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME;

ADMINISTRATION, INTRAVENOUS; ADMINISTRATION, ORAL; ADULT; ANTIHYPERTENSIVE AGENTS; COST-BENEFIT ANALYSIS; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; HYPERTENSION, PREGNANCY-INDUCED; LABETALOL; NIFEDIPINE; PRACTICE PATTERNS, PHYSICIANS'; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; TREATMENT OUTCOME;

EID: 84952863083     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/1471-0528.13463     Document Type: Review

References (27)

1. Roberts JM, Pearson GD, Cutler JA, Lindheimer MD, National Heart Lung and Blood Institute. Summary of the NHLBI working group on research on hypertension during pregnancy. Hypertens Pregnancy 2003; 22: 109-27.
2. National Institute of Health and Clinical Excellence. Hypertension in pregnancy. The management of hypertensive disorders during pregnancy. Clinical guidelines CG107. Issued: August 2010 [Internet]. [ http://www.nice.org.uk/ ]. Accessed 20 June 2014.
3. Rey E, LeLorier J, Burgess E, Lange IR, Leduc L,. Report of the Canadian Hypertension Society Consensus Conference: 3. pharmacologic treatment of hypertensive disorders in pregnancy. CMAJ 1997; 157: 1245-54.
4. Report of the national high blood pressure education program working group on high blood pressure in pregnancy. Am J Obstet Gynecol 2000; 183: S1-22.
5. Brown M, Hague W, Higgins J, Lowe S, McCowan L, Oats J, et al., The detection, investigation and management of hypertension in pregnancy: executive summary. Aust N Z J Obstet Gynaecol 2000; 40: 133-8.
6. Duley L, Meher S, Jones L,. Drugs for treatment of very high blood pressure during pregnancy. Cochrane Database Syst Rev 2013;(7): CD001449.
7. Magee LA, Helewa M, Moutquin J-M, von Dadelszen P, Hypertension Guideline Committee, Strategic Training Initiative in Research in the Reproductive Health Sciences (STIRRHS) Scholars. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy. J Obstet Gynaecol Can 2008; 30 (Suppl 3): S1-48.
8. Committee on Obstetric Practice. Committee Opinion no. 514: emergent therapy for acute-onset, severe hypertension with preeclampsia or eclampsia. Obstet Gynecol 2011; 118: 1465-8.
9. Magee LA, Cham C, Waterman EJ, Ohlsson A, von Dadelszen P,. Hydralazine for treatment of severe hypertension in pregnancy: meta-analysis. BMJ 2003; 327: 955-60.
10. Magee LA, Ornstein MP, von Dadelszen P,. Fortnightly review: management of hypertension in pregnancy. BMJ 1999; 318: 1332-6.
11. Bolte AC, van Geijn HP, Dekker GA,. Pharmacological treatment of severe hypertension in pregnancy and the role of serotonin(2)-receptor blockers. Eur J Obstet Gynecol Reprod Biol 2001; 95: 22-36.
12. Anonymous. What treatment did you use in your last case of hypertensive emergency in pregnancy? Quick Poll. Obstet Gynecol, November 2013.
13. Heazell AEP, Mahomoud S, Pirie AM,. The treatment of severe hypertension in pregnancy: a review of current practice and knowledge in West-Midlands maternity units. J Obstet Gynaecol 2004; 24: 897-8.
14. Desai BB, Swamy MK, Patil KP,. A randomized controlled trial of oral nifedipine vs intravenous labetalol in acute control of blood pressure in hypertensive emergencies of pregnancy. 54th All India Congress of Obstetrics & Gynecology. Hyderabad, Andhra Pradesh, India, 2011.
15. Dhali B, Bhattacharya S, Ganguly R, Bandyopadhyay S, Mondal M, Dutta M,. A randomized trial of intravenous labetalol and oral nifedipine in severe pregnancy-induced hypertension. Int J Reprod Contracept Obstet Gynecol 2012; 1: 42.
16. Vermillion ST, Scardo JA, Newman RB, Chauhan SP,. A randomized, double-blind trial of oral nifedipine and intravenous labetalol in hypertensive emergencies of pregnancy. Am J Obstet Gynecol 1999; 181: 858-61.
17. Aswathkumar R, Gilvaz S,. Management of severe hypertension in pregnancy: prospective comparison of labetalol vs nifedipine (abstract). 49th All India Congress of Obstetrics and Gynaecology; 6-9 January 2006; Cochin, Kerala, India, 2006, pp. 38.
18. Shekhar S, Sharma C, Thakur S, Verma S,. Oral nifedipine or intravenous labetalol for hypertensive emergency in pregnancy: a randomized controlled trial. Obstet Gynecol 2013; 122: 1057-63.
19. Raheem IA, Saaid R, Omar SZ, Tan PC,. Oral nifedipine versus intravenous labetalol for acute blood pressure control in hypertensive emergencies of pregnancy: a randomised trial. BJOG 2012; 119: 78-85.
20. Lakshmi BS, Dasari P,. Oral nifedipine versus intravenous labetalol in hypertensive urgencies and emergencies of pregnancy: a randomized clinical trial. Obstet Med Med Pregnancy 2012; 5: 171-5.
21. Saudan P, Billieux M-H, Pechere A, Irion O, Savoldelli G, Boulvain M,. OS014. Which first-line drug to control severe hypertension in pregnancy? A pilot study. Pregnancy Hypertens Int J Womens Cardiovasc Health 2012; 2: 182.
22. Shi Q, Leng W, Yao Q, Mi C, Xing A,. Oral nifedipine versus intravenous labetalol for the treatment of severe hypertension in pregnancy. Int J Cardiol 2015; 178: 162-4.
23. Higgins JPT, Green S, (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (Updated March 2011). Wiley Cochrane Series, The Cochrane Collaboration, 2011. [ www.cochrane-handbook.org ]. Accessed 9 April 2014.
24. GRADEpro. Computer Program on www.gradepro.org. Version [28 Jun 2014]. Hamilton: McMaster University, 2014.
25. Waisman GD, Mayorga LM, Cámera MI, Vignolo CA, Martinotti A,. Magnesium plus nifedipine: potentiation of hypotensive effect in preeclampsia? Am J Obstet Gynecol 1988; 159: 308-9.
26. Ben-Ami M, Giladi Y, Shalev E,. The combination of magnesium sulphate and nifedipine: a cause of neuromuscular blockade. BJOG 1994; 101: 262-3.
27. Magee LA, Miremadi S, Li J, Cheng C, Ensom MHH, Carleton B, et al., Therapy with both magnesium sulfate and nifedipine does not increase the risk of serious magnesium-related maternal side effects in women with preeclampsia. Am J Obstet Gynecol 2005; 193: 153-63.